Surgical management of colorectal cancer metastases to the liver: multimodality approach and a single institutional experience.

IF 2.7 Q3 ONCOLOGY Colorectal Cancer Pub Date : 2013-02-01 DOI:10.2217/crc.12.80
Aaron U Blackham, Katrina Swett, Edward A Levine, Perry Shen
{"title":"Surgical management of colorectal cancer metastases to the liver: multimodality approach and a single institutional experience.","authors":"Aaron U Blackham,&nbsp;Katrina Swett,&nbsp;Edward A Levine,&nbsp;Perry Shen","doi":"10.2217/crc.12.80","DOIUrl":null,"url":null,"abstract":"<p><p>Over the past 30 years, the treatment of metastatic colorectal cancer to the liver has undergone major changes. Once considered terminal and incurable, the prognosis of patients with colorectal hepatic metastases has seen dramatic improvements using modern multimodality therapy and now long-term survival and even cure are possible in some patients. Despite the advances seen in systemic therapy, hepatic resection offers the longest survival potential and remains the only curative option. Based on long-term outcomes and the improved safety of hepatic resection using modern operative techniques and critical care support, an aggressive locoregional approach to colorectal hepatic metastasis has become the standard of care. This article focuses on the management of colorectal hepatic metastases and highlights the importance of multimodality therapy. We also report our 18-year experience treating patients with hepatic resection for colorectal metastases.</p>","PeriodicalId":43638,"journal":{"name":"Colorectal Cancer","volume":"2 1","pages":"73-88"},"PeriodicalIF":2.7000,"publicationDate":"2013-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/crc.12.80","citationCount":"13","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Colorectal Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2217/crc.12.80","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 13

Abstract

Over the past 30 years, the treatment of metastatic colorectal cancer to the liver has undergone major changes. Once considered terminal and incurable, the prognosis of patients with colorectal hepatic metastases has seen dramatic improvements using modern multimodality therapy and now long-term survival and even cure are possible in some patients. Despite the advances seen in systemic therapy, hepatic resection offers the longest survival potential and remains the only curative option. Based on long-term outcomes and the improved safety of hepatic resection using modern operative techniques and critical care support, an aggressive locoregional approach to colorectal hepatic metastasis has become the standard of care. This article focuses on the management of colorectal hepatic metastases and highlights the importance of multimodality therapy. We also report our 18-year experience treating patients with hepatic resection for colorectal metastases.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
结直肠癌肝转移的外科治疗:多模式方法和单一机构经验。
在过去的30年里,肝转移性结直肠癌的治疗发生了重大变化。曾经被认为是终末期和无法治愈的结直肠癌肝转移患者的预后已经有了显着的改善,使用现代多模式治疗,现在一些患者可以长期生存甚至治愈。尽管在全身治疗方面取得了进展,但肝切除术提供了最长的生存潜力,仍然是唯一的治疗选择。基于长期预后和使用现代手术技术和危重监护支持的肝切除术安全性的提高,积极的局部方法治疗结直肠癌肝转移已成为治疗标准。本文重点介绍了结直肠肝转移的治疗,并强调了多模式治疗的重要性。我们也报告了我们18年来治疗结肠直肠癌肝切除患者的经验。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Colorectal Cancer
Colorectal Cancer ONCOLOGY-
自引率
0.00%
发文量
0
期刊介绍: Colorectal cancer is a major cause of morbidity and mortality, particularly in the developed world. Risk factors for colorectal cancer are on the rise in many countries; populations are aging, and obesity and diabetes are increasing. National screening programs are helping to detect cancer while it is still curable; however, colorectal cancer remains the third leading cause of cancer deaths in the USA and options are still limited for those with more advanced disease. Consequently, colorectal cancer is a major research priority for government, pharmaceutical companies and non-profit organizations. Research into diagnosis and optimum treatment of the disease is progressing rapidly, with new advances reported every day. Colorectal Cancer presents reviews, analysis and commentary. on all aspects of colorectal cancer.
期刊最新文献
The role of colorectal cancer plasticity in metastasis and treatment: an interview with Mirjana Efremova Prognostic significance of the diameter of superior rectal vein for locally advanced rectal cancer Clinical and quality of life outcomes with trifluridine/tipiracil: PRECONNECT and TALLISUR studies Colorectal cancer incidence and mortality: trends from the Pennsylvania Cancer Registry across three decades Exosome-derived miRNAs regulate macrophage-colorectal cancer cell cross-talk during aggressive tumor development
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1